

Health Care: Drugs
Isis Pharmaceuticals (ISIS: NASDAQ)
$20.66 0.50 | 2.48%
05/17/13 - 04:00 PM ET
Insider Trading
 |
| Historical Data |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
4 Mo. Ago |
5 Mo. Ago |
6 Mo. Ago |
| Net Insider Transaction |
-45,566 |
4,434 |
4,434 |
41,076 |
41,076 |
40,314 |
7,659 |
| Shares Bought |
469,398 |
139,149 |
12,293 |
308,611 |
308,611 |
343,056 |
64,445 |
| Shares Sold |
514,964 |
134,715 |
7,859 |
267,535 |
267,535 |
302,742 |
56,786 |
Institutional Trading
 |
| Historical Data |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
4 Mo. Ago |
5 Mo. Ago |
6 Mo. Ago |
| Total Shares Held |
82.31M |
78.91M |
78.87M |
80.18M |
80.97M |
78.81M |
78.30M |
| Shares Bought |
11.08M |
16.59M |
16.30M |
16.08M |
11.30M |
8.41M |
8.27M |
| Shares Sold |
12.21M |
10.82M |
10.00M |
14.52M |
5.52M |
7.19M |
6.01M |
Partner Headlines for ISIS
- Cree, Seagate, Sandisk: Why Richie Freeman Likes Them - Investor's Business Daily 04.02.13 | 06:04 pm
- Isis Pharma Issues Update on CHMP Opinion on KYNAMRO - Benzinga 03.22.13 | 02:03 pm
- Revenues Decline at Alnylam - Analyst Blog - Zacks 11.07.12 | 09:11 am
- Isis Pharmaceuticals To Receive $1.1 Million From Alnylam - Benzinga 10.23.12 | 01:10 pm
- Benzinga Mid-Day Market Update - Benzinga 10.17.12 | 12:10 pm
- UPDATE: Piper Jaffray Downgrades ISIS Pharmaceuticals to Neutral on FDA Briefing - Benzinga 10.16.12 | 01:10 pm
- Alnylam-ISIS Venture Prices IPO - Analyst Blog - Zacks 10.05.12 | 06:10 pm
- Alnylam/Isis's Regulus to Go Public - Analyst Blog - Zacks 08.22.12 | 07:08 pm
- Biogen Inks Deal with Regulus - Analyst Blog - Zacks 08.16.12 | 06:08 pm
- Pre-Market Most Active for Aug 8, 2012 : WFR, QQQ, NOK, BAC, TEF, DF, KCG, SODA, ISIS, SIRI, FB, ASML - NASDAQ 08.08.12 | 12:08 pm